Avanos Medical AVNS Change in derivative financial instruments
Change in derivative financial instruments at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's change in derivative financial instruments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's change in derivative financial instruments?
- Avanos Medical (AVNS) reported change in derivative financial instruments of $1.5M in Q1 2026.
- How has Avanos Medical's change in derivative financial instruments changed year-over-year?
- Avanos Medical's change in derivative financial instruments increased by 1600.0% year-over-year, from -$100K to $1.5M.
- What does change in derivative financial instruments mean?
- Represents the effective portion of gains or losses on derivative instruments designated as cash flow hedges. This metric tracks the company's success in mitigating risks associated with interest rate, commodity, or currency fluctuations.